InMed Pharmaceuticals Inc. financial data

Symbol
INM on Nasdaq
Location
1445 885 West Georgia St., Vancouver, British Columbia, Canada
Fiscal year end
June 30
Latest financial report
10-Q - Q3 2025 - Nov 6, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 506 %
Quick Ratio 53.7 %
Debt-to-equity 22.2 %
Return On Equity -85.9 % -30.7%
Return On Assets -70.3 %
Operating Margin -148 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 2.38M shares -82.1%
Common Stock, Shares, Outstanding 2.6M shares +290%
Entity Public Float 3.32M USD +41%
Common Stock, Value, Issued 91.8M USD +9.04%
Weighted Average Number of Shares Outstanding, Basic 3.95M shares +538%
Weighted Average Number of Shares Outstanding, Diluted 3.95M shares +538%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 4.8M USD -3.27%
Cost of Revenue 3.18M USD -6.07%
Research and Development Expense 2.74M USD +4.18%
General and Administrative Expense 6.6M USD +10.1%
Costs and Expenses -2.34M USD +37.1%
Operating Income (Loss) -6.97M USD +63.6%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -8.21M USD -20.6%
Net Income (Loss) Attributable to Parent -8.21M USD -20.5%
Earnings Per Share, Basic -6 USD/shares +20%
Earnings Per Share, Diluted -6 USD/shares +20%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 9.33M USD +67.1%
Cash, Cash Equivalents, and Short-term Investments 9.4M USD +67.9%
Accounts Receivable, after Allowance for Credit Loss, Current 343K USD +20.6%
Inventory, Net 891K USD -27%
Assets, Current 10.8M USD +48.4%
Property, Plant and Equipment, Net 882K USD -34.4%
Intangible Assets, Net (Excluding Goodwill) 1.58M USD -9.34%
Other Assets, Noncurrent 100K USD 0%
Assets 13.4M USD +27.7%
Accounts Payable, Current 2K USD
Employee-related Liabilities, Current 274K USD
Accrued Liabilities, Current 85.5K USD
Liabilities, Current 1.55M USD +8.3%
Operating Lease, Liability, Noncurrent 215K USD -66%
Liabilities 1.77M USD -14.5%
Accumulated Other Comprehensive Income (Loss), Net of Tax 129K USD 0%
Retained Earnings (Accumulated Deficit) -119M USD -7.41%
Stockholders' Equity Attributable to Parent 11.6M USD +38.1%
Liabilities and Equity 13.4M USD +27.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.61M USD +12%
Net Cash Provided by (Used in) Financing Activities -137K USD -116%
Common Stock, Shares, Issued 2.6M shares +290%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 9.33M USD +67.1%
Deferred Tax Assets, Valuation Allowance 26.8M USD +18.4%
Deferred Tax Assets, Gross 26.8M USD +18.4%
Operating Lease, Liability 640K USD -39.5%
Depreciation 50.2K USD +5.16%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -15.5M USD -10.7%
Lessee, Operating Lease, Liability, to be Paid 668K USD -41.5%
Property, Plant and Equipment, Gross 2.33M USD -10.5%
Operating Lease, Liability, Current 425K USD +0.12%
Lessee, Operating Lease, Liability, to be Paid, Year Two 219K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 449K USD -0.92%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 28K USD -66.7%
Lessee, Operating Lease, Liability, to be Paid, Year Three 219K USD -80%
Deferred Tax Assets, Operating Loss Carryforwards 5.4M USD -28%
Additional Paid in Capital 38.1M USD -0.74%
Amortization of Intangible Assets 163K USD -5.37%
Depreciation, Depletion and Amortization 53.2K USD -2.52%
Share-based Payment Arrangement, Expense 20.2K USD -85.7%